| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 10/03/2001 | CN1315861A Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for treatment of sleep disorders |
| 10/03/2001 | CN1315319A Process for preparing ethyl-sulfonylpiperidine derivatives |
| 10/02/2001 | USH1996 Agriculture |
| 10/02/2001 | US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297259 Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl) benzamides useful for the treatment of allergic diseases |
| 10/02/2001 | US6297247 Particularly stromelysin-1 and gelatinase a (72 kd gelatinase) |
| 10/02/2001 | US6297233 Lactam inhibitors of FXa and method |
| 10/02/2001 | CA2212451C Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds |
| 10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070691A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070688A2 N-(2,6-dioxo-piperidin-3-yl) benzamides and their use as immune modulators |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070670A1 Novel phenylalanine derivative |
| 09/27/2001 | WO2001070230A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 09/27/2001 | WO2001070223A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
| 09/27/2001 | WO2001070222A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | US20010025106 Antiallergens, bronchodilator |
| 09/27/2001 | US20010025052 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/27/2001 | US20010025041 Amidino protease inhibitors |
| 09/27/2001 | DE10013499A1 New N-(2,6-dioxo-piperidin-3-yl)-benzamide derivatives, useful as immunomodulators causing no general immunosuppression, is useful for the treatment of inflammatory or autoimmune disease |
| 09/27/2001 | CA2404131A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2400637A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma |
| 09/27/2001 | CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | CA2399985A1 Compounds with 5-ht activity useful for controlling visual field loss |
| 09/26/2001 | EP1136490A1 New forms of paroxetin hydrochloride |
| 09/26/2001 | EP1136475A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer |
| 09/26/2001 | EP1135379A1 Antitumor dibenzofluorene derivatives |
| 09/26/2001 | EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 09/26/2001 | EP0799201B1 Process for the preparation of substituted 4-ethyl-piperidines |
| 09/26/2001 | CN1314888A Crystalline forms of osanetant |
| 09/26/2001 | CN1314887A Ester of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/25/2001 | US6294673 Mixing methyl 2-(2-nitrobenzylidene) acetoacetate and methyl 3-aminocrotonate in alkanol solvent in absence of catalylst; heating reaction mixture in closed container; isolating nifedipine |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294555 1-[(1-Substituted-4-piperidinyl)methyl]-4-piperidine derivative, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 09/25/2001 | US6294554 Muscarinic antagonists |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294544 Blood flow increased in vessels for eyes in mammals |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/20/2001 | WO2001068645A2 N-cyanomethylcarboxamides and their use as protease inhibitors |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068606A1 Process for preparing sterically hindered n-oxyl compounds |
| 09/20/2001 | WO2001068605A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| 09/20/2001 | WO2001068604A2 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| 09/20/2001 | WO2001068588A1 POLYMER-IMMOBILIZED α-IMINOESTER |
| 09/20/2001 | WO2001068575A1 Fluoroalkylonium salt type cation or acid generator generating cation or acid upon irradiation with energy ray |
| 09/20/2001 | WO2001068140A2 Opioid formulations |
| 09/20/2001 | WO2000071506A9 Naphthalene ureas as glucose uptake enhancers |
| 09/20/2001 | US20010023269 Materials handling; fluid flow |
| 09/20/2001 | US20010023249 Calcium channel blockers |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402865A1 Opioid formulations |
| 09/19/2001 | EP1133489A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 09/19/2001 | EP1133473A1 New manufacturing process |
| 09/19/2001 | EP0869954B1 Heterocyclic compounds for use in the treatment of neurogenic inflammation |
| 09/19/2001 | EP0800516B1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313847A Method for preparing alkoxyamines from nitroxides |
| 09/19/2001 | CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/18/2001 | US6291722 Contacting grignard reagent of formula r.sup.7--mgx with an aryl compound of the formula r.sup.1--x in the presence of a catalytic amount of coordination comprising trasition metal complexed to phosphine oxide to prepare bisaryl compound |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291657 N-butyldeoxygalactonojirimycin; suppression of glycolipid biosynthesis; microbiocides; treatment of gaucher's disease |
| 09/18/2001 | US6291481 Conditions related to a hampered or impaired gastric emptying and more generally to treat conditions related to a hampered or impaired gastrointestinal transit. |
| 09/18/2001 | US6291478 Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6291417 Cleaning process |
| 09/18/2001 | US6289745 High temperature insertion type flow element and mounting extension |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066114A1 Novel methods using cholinesterase inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | US20010021791 Cyclopropyl phenyl ketone compound |
| 09/13/2001 | US20010021778 Oxidizing a 4-phenyl-N-acyldihydropyridine |
| 09/13/2001 | US20010021715 Gastrointestinal disorders |
| 09/12/2001 | EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 09/12/2001 | EP1132370A2 Process for producing n-substituted polyhydroxy nitrogen-containing heterocyles |
| 09/12/2001 | EP1132085A1 Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient |
| 09/12/2001 | EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 09/12/2001 | EP1131290A1 Piperidine ccr-3 receptor antagonists |
| 09/12/2001 | EP1131289A1 Processes for preparing 2-piperidineethanol compounds |
| 09/12/2001 | EP0820450B1 N-substituted azaheterocyclic carboxylic acids and alkylesters thereof |
| 09/12/2001 | EP0682514B1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 09/12/2001 | CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 09/12/2001 | CN1312799A Bispiperidines as antithrombotic agents |
| 09/12/2001 | CN1312716A Use of optically pure (-)-norcisapride in treatment of apnea, bulimta and other disorders |
| 09/12/2001 | CN1070831C Stabilized monomer composition |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288123 Therapeutic guanidines |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |